| Ytd | 10.58% | |
| 1y | 10.58% |
| Open | 24.79 | Prev Close | 24.10 | Low | 23.86 | High | 25.00 | Mkt Cap | 1.32B |
| Vol | 0.00 | Avg Vol | 359.25K | EPS | -18.57 | P/E | -1.33 | Forward P/E | -12.25 |
| Beta | N/A | Short Ratio | 5.92 | Inst. Own | 75.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 24.29 | 200-d Avg | 20.99 | 1yr Est | 34.38 |
AKTS News
JP Morgan analyst Jessica Fye maintains Aktis Oncology (NASDAQ:AKTS) with a Overweight and raises
US stocks were mixed, Nasdaq fell 1%. DigitalOcean shares rose after strong revenue growth and earni
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's
Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrade
U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and o
Aktis Oncology trades at a $1.1B market cap with $540M cash, pricing its pipeline and Eli Lilly coll
BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clini
BOSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company),
This clinical-stage biotech develops targeted radiopharmaceutical therapies for cancer using a propr
BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company),
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clini
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company),
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform rating
Aktis Oncology is initiated with a "Buy" rating, driven by its innovative miniprotein radioconjugate
The mean of analysts' price targets for Aktis (AKTS) points to a 74.7% upside in the stock. While th
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a cli
BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a cli
Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst r
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS), a clinical-stage oncol
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS), a clinical-stage oncol
In the past week, a beneficial owner has continued to build a stake in insurance giant W.R.
Guru Stock PicksAndreas Halvorsen has made the following transactions:Add in RRX by 5.71%Stock News
For speculative investors, the start of each year is always a good time to revisit an initial public
Stock News Saks Global files Chapter 11: Saks Global (private) sought Chapter 11 protection, citing
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its
Friday's session saw 225 companies set new 52-week lows.
On Thursday, 283 companies set new 52-week lows.
On Wednesday, 179 companies reached new 52-week lows.
On Wednesday, 59 companies achieved new lows for the year.
During Tuesday's trading, 188 companies set new 52-week lows.
During Wednesday's trading, 103 companies set new 52-week lows.
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe